If there’s one thing health care professionals can agree on, it’s that the shift to value-based medicine will significantly impact the way we do business in the very near future if it hasn’t already. Between new quality incentive programs, such as CMS’s Merit-Based Incentive Payment System, and the continued rush to consolidate within all parts of the industry, it can be difficult to keep track of how this cascade of changes not only affects your day-to-day operations, but also your revenue.
Mick Raich, president of Vachette Pathology and Stark Medical Auditing and Consulting, has traveled throughout the country this year to various health care tradeshows and conferences to share his insight on how the health care industry’s ongoing transition to value-based medicine will impact your revenue stream, and more importantly, what you can do to prepare. During this Power Point presentation, Raich outlines several revenue-impacting changes the industry has faced so far in 2016, in addition to a few others that will take effect in the near future. (Note: Some subjects addressed in this recording, such as MIPS, were still in draft form at the time of the presentation.)